Erasca share price logo

Erasca

NASDAQ: ERAS

Mid Cap

$14.26

-0.26

(-1.83%)

as on

Erasca Stock Performance

as on September 26, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $14.24
    $14.88
    downward going graph

    0.14%

    Downside

    4.35%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.78
    $24.28
    downward going graph

    87.55%

    Downside

    70.27%

    Upside

    downward going graph

Erasca share price movements today

Previous Close
$14.52
Open
$14.68
Volume
2.4M
Market Cap
$4.9B
Day's Low - High
$14.24 - $14.88
52 Week Low - High
$1.78 - $24.28

Erasca Historical Returns

1 Month Return
-18.24 %
3 Month Return
-2.88 %
1 Year Return
+ 702.21 %
3 Year Return
+ 584.91 %
5 Year Return
-24.53 %

Erasca Stock Fundamentals & Key Indicators

Check Erasca market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.9B

EPS (TTM)

-0.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-14.68

Industry PE ratio

-15.36

PEG Ratio

0.13180774215736346

EBITDA

-284.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-80.43%

Erasca Stock Valuation

Track how Erasca P/E has moved over time to understand its valuation trends.

Erasca in the last 5 years

  • Overview

  • Trends

Lowest (-15.12x)

December 31, 2021

Industry (-15.36x)

December 31, 2025

Today (-8.45x)

December 31, 2025

Highest (-2.17x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -8.45x

Erasca vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Erasca with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$4.9B-24.53%-14.680.00%0.00%
Neutral$72.7B-54.71%-22.82-12.57%0.00%
StrongBuy$130.9B184.51%29.8186.04%0.00%
Buy$82.8B24.59%19.1584.86%0.46%

Stock Returns calculator for Erasca Stock including INR - Dollar returns

The Erasca stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Erasca investment value today

Current value as on today

₹8,50,372

Returns

₹7,50,372

(+750.37%)

Returns from Erasca Stock

₹6,87,845 (+687.85%)

Dollar Impact

₹62,527 (+62.53%)

Analyst Recommendation on Erasca Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Erasca. Average target price of $24.11

Erasca Share Price Target

Get share price movements and forecasts by analysts on Erasca.

What analysts predicted

40.85%UPSIDE

Target Price

$24.11

Current Price

$14.26

Analyzed by

7 Analysts

High

$33

Target

$24.11

Low

$21

Erasca target price $24.11, a slight upside of 40.85% compared to current price of $14.26. According to 7 analysts rating.

Indian Investors' Interest in Erasca Stock

Search interest for Erasca Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Erasca Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
0
-
-
-
0
0
-
Operating Income
-38
-67
-37
-35
-35
-38
-34
-32
-37
-47
EBITDA
-34
-44
-30
-31
-30
-29
-29
-28
-182
-43
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
1
0
0
0
0
0
0
0
0
Income Before Tax
-35
-63
-31
-32
-30
-33
-30
-29
-183
-44
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-35
-63
-31
-32
-30
-33
-30
-29
-183
-44
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Erasca Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
0
-2
-3
-
-3
Operating Income
-13
-109
-124
-247
-141
-179
-131
EBITDA
-12
-36
-121
-240
-121
-153
-121
Interest Expense
-
-
-
201
-
-
-
Depreciation
0
0
0
2
3
3
3
Income Before Tax
-12
-101
-122
-242
-125
-161
-124
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-12
-101
-122
-242
-125
-161
-124
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Erasca Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-35
-63
-31
-32
-30
-33
-30
-29
-183
-44
Operating Cash Flow
-33
-29
-22
-24
-31
-20
-21
-21
-27
-27
Investing Cash Flow
9
-86
-102
22
34
15
25
24
-243
19
Financing Cash Flow
6
211
21
0
0
0
0
0
244
3
Change in Cash
-16
96
-103
-1
2
-4
4
3
-26
-4

Erasca Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-101
-122
-242
-125
-161
-124
Operating Cash Flow
-10
-32
-79
-103
-101
-109
-95
Investing Cash Flow
-20
-71
-64
-71
-91
-156
100
Financing Cash Flow
16
139
439
98
1
240
1
Change in Cash
-14
36
295
-76
-191
-25
6

Mutual Funds that own Erasca Stock

Check out the Mutual Funds with significant holdings in Erasca.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.135832%
10967952
T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
1.98838%
6954600
Fidelity Salem Street Trust
0.775017%
2710718
T. ROWE PRICE SMALL-CAP STOCK FUND, INC.
0.728312%
2547359
Fidelity Concord Street Trust
0.68765%
2405141

Global Institutional Holdings in Erasca

Funds
Holdings
Vanguard
4.39%
iShares
3.17%
VANGUARD INDEX FUNDS
3.14%
SPDR
2.65%
T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
1.99%

Erasca News & Key Events

  • img

    Today's Timeline - 28 April

    Tue, 10:08 PM

    -

    Erasca shares fell nearly 50% after disclosing a patient death in an early-stage trial of its ERAS-0015 cancer drug.

Insights on Erasca

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ERAS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ERAS stock has moved up by 702.2%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ERAS has outperformed top 5 stocks with highest market-cap in its industry

About Erasca

Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on identifying, advancing, and commercializing therapeutic solutions for malignancies propelled by the RAS/MAPK pathway. The firm's pipeline features several key experimental drugs: ERAS-007, an orally administered ERK1/2 inhibitor designed to address non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor targeting patients with advanced or metastatic solid tumors. Additionally, Erasca is progressing ERAS-801, an EGFR inhibitor capable of penetrating the central nervous system, intended for recurrent glioblastoma multiforme. The company was founded in 2018 and maintains its headquarters in San Diego, California.
OrganisationErasca
Headquarters3115 Merryfield Row, San Diego, CA, 92121, US
IndustryBiotechnology
CEOJonathan E. Lim
E-voting on sharesClick here to vote

Key Management of Erasca

Name

Title

Dr. Lisa Tesvich-Bonora Ph.D.

Chief People Officer

Dr. Jonathan E. Lim M.D.

Co-Founder, Chairman & CEO

Ms. Alison Tjosvold Milhous

Senior Vice President of Accounting

Mr. Ebun S. Garner Esq., J.D.

Chief Legal Officer & Corporate Secretary

Dr. Nik Chetwyn Ph.D.

Chief Operating Officer

Dr. Robert Shoemaker Ph.D.

Chief Scientific Officer

Mr. Brian L. Baker CPA, M.S.

Senior Vice President of Finance

Dr. David M. Chacko M.D.

CFO & Chief Business Officer

Dr. Michael D. Varney Ph.D.

Chairman of Research & Development, Scientific Advisory Board Member and Director

Dr. Shannon R. Morris M.D., Ph.D.

Chief Medical Officer

FAQs

What is Erasca share price today?

Erasca share price today is $14.26 as on at the close of the market. Erasca share today touched a day high of $14.88 and a low of $14.24.

What is the 52 week high and 52 week low for Erasca share?

Erasca share touched a 52 week high of $24.28 on and a 52 week low of $1.78 on . Erasca stock price today i.e. is closed at $14.26,which is 41.27% down from its 52 week high and 703.38% up from its 52 week low.

What is Erasca's market capitalisation today?

Erasca market capitalisation is $0.00T as on .

How to invest in Erasca Stock (ERAS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Erasca on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Erasca Shares that will get you 0.1052 shares as per Erasca share price of $14.26 per share as on September 26, 2026 at 1:29 am IST.

What is the minimum amount required to buy Erasca Stock (ERAS) from India?

Indian investors can start investing in Erasca (ERAS) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Erasca stock (as per the Rupee-Dollar exchange rate as on ). Based on Erasca share’s latest price of $14.26 as on September 26, 2026 at 1:29 am IST, you will get 0.7013 shares of Erasca. Learn more about fractional shares .

What are the returns that Erasca has given to Indian investors in the last 5 years?

Erasca stock has given -24.53% share price returns and 29.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?